Teladoc Health (NYSE:TDOC) Price Target Raised to $9.00

Teladoc Health (NYSE:TDOC) had its price target hoisted by Evercore ISI from $8.00 to $9.00 in a research note published on Wednesday,Benzinga reports. They currently have an in-line rating on the health services provider’s stock.

A number of other equities research analysts have also issued reports on TDOC. Weiss Ratings restated a “sell (d-)” rating on shares of Teladoc Health in a research report on Saturday, September 27th. Mizuho began coverage on Teladoc Health in a report on Friday, July 25th. They issued a “neutral” rating and a $10.00 target price for the company. Six equities research analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Teladoc Health currently has an average rating of “Hold” and a consensus price target of $9.86.

Teladoc Health Stock Down 9.4%

Teladoc Health stock opened at $8.02 on Wednesday. The stock has a market capitalization of $1.42 billion, a PE ratio of -6.74 and a beta of 1.90. Teladoc Health has a 12 month low of $6.35 and a 12 month high of $15.21. The business has a 50 day simple moving average of $7.77 and a 200-day simple moving average of $7.60. The company has a debt-to-equity ratio of 0.70, a current ratio of 2.67 and a quick ratio of 2.58.

Teladoc Health (NYSE:TDOC) last released its earnings results on Tuesday, July 29th. The health services provider reported ($0.19) EPS for the quarter, topping analysts’ consensus estimates of ($0.27) by $0.08. Teladoc Health had a negative net margin of 8.16% and a negative return on equity of 10.13%. The business had revenue of $631.90 million during the quarter, compared to analysts’ expectations of $621.91 million. During the same quarter in the previous year, the company earned ($0.38) earnings per share. The company’s quarterly revenue was down 1.6% on a year-over-year basis. Teladoc Health has set its Q3 2025 guidance at -0.350–0.200 EPS. FY 2025 guidance at -1.350–1.000 EPS. On average, analysts anticipate that Teladoc Health will post -1.16 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the company. Golden State Wealth Management LLC lifted its position in shares of Teladoc Health by 102.6% during the 1st quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider’s stock worth $27,000 after purchasing an additional 1,690 shares during the last quarter. National Bank of Canada FI lifted its holdings in Teladoc Health by 79.4% during the 1st quarter. National Bank of Canada FI now owns 3,571 shares of the health services provider’s stock worth $28,000 after buying an additional 1,581 shares during the last quarter. SVB Wealth LLC purchased a new stake in Teladoc Health during the 1st quarter worth about $37,000. BI Asset Management Fondsmaeglerselskab A S purchased a new stake in Teladoc Health during the 1st quarter worth about $50,000. Finally, Caitong International Asset Management Co. Ltd lifted its holdings in Teladoc Health by 8,192.0% during the 2nd quarter. Caitong International Asset Management Co. Ltd now owns 8,292 shares of the health services provider’s stock worth $72,000 after buying an additional 8,192 shares during the last quarter. Hedge funds and other institutional investors own 76.82% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.